Back to search

Article

Amelioration of the Pharmacokinetics and Tissue Distribution of Flurbiprofen Axetil by Glycyrrhetinic Acid Derivatives for Enhanced Safety and Efficacy

2026-03-16

Abstract excerpt

Flurbiprofen axetil, an ester prodrug of flurbiprofen, undergoes premature hydrolysis in the gastrointestinal tract, causing mucosal injury and limiting its oral application. This study re-identified carboxylesterase 2 (CES2) as the primary enzyme responsible for this hydrolysis. Using glycyrrhetinic acid derivative GA13 as a selective CES2 inhibitor, we evaluated its effects on flurbiprofen pharmacokinetics, tiss...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
86869a5d-467f-520e-875e-e66cf7b4ac75
DOI
10.22541/au.177366304.43880019/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Amelioration of the Pharmacokinetics and Tissue Distribution of Flurbiprofen Axetil by Glycyrrhetinic Acid Derivatives for Enhanced Safety and EfficacyDOI 10.22541/au.177366304.43880019/v1
Select a neighboring publication to make it the new centre.